Edition:
United States

Hologic Inc (HOLX.OQ)

HOLX.OQ on NASDAQ Stock Exchange Global Select Market

41.17USD
4:00pm EDT
Change (% chg)

$0.24 (+0.59%)
Prev Close
$40.93
Open
$41.04
Day's High
$41.30
Day's Low
$40.94
Volume
443,950
Avg. Vol
671,669
52-wk High
$45.09
52-wk Low
$35.10

Chart for

About

Hologic, Inc. is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women's health. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The diagnostics products include Aptima family of assays,... (more)

Overall

Beta: 0.68
Market Cap(Mil.): $11,137.99
Shares Outstanding(Mil.): 272.12
Dividend: --
Yield (%): --

Financials

  HOLX.OQ Industry Sector
P/E (TTM): -- 47.80 32.65
EPS (TTM): -1.57 -- --
ROI: -7.13 8.26 12.72
ROE: -16.32 12.17 14.84

Hologic wins $4.8 million from Minerva Surgical in patent trial

A federal jury on Friday awarded medical device maker Hologic Inc $4.8 million in its patent infringement lawsuit against rival Minerva Surgical Inc.

Jul 30 2018

BRIEF-Hologic Receives Health Canada Authorization To Market Sculpsure Laser

* HOLOGIC RECEIVES HEALTH CANADA AUTHORIZATION TO MARKET SCULPSURE® LASER FOR NON-INVASIVE BODY CONTOURING (LIPOLYSIS) OF THE BACK, INNER AND OUTER THIGHS, AND UNDER THE CHIN Source text for Eikon: Further company coverage:

May 03 2018

BRIEF-Hologic Q2 GAAP Loss Per Share $2.46

* HOLOGIC ANNOUNCES FINANCIAL RESULTS FOR SECOND QUARTER OF FISCAL 2018

May 02 2018

BRIEF-FDA Approval Of Thinprep Integrated Imager Expands Automated Imaging For Pap Testing To More Labs

* FDA APPROVAL OF THINPREP® INTEGRATED IMAGER EXPANDS AUTOMATED IMAGING FOR PAP TESTING TO MORE LABS

Apr 25 2018

BRIEF-Enzo Biochem Says Patent Trial And Appeal Board Has Denied A Petition Filed By Hologic For Inter Partes Review

* ENZO BIOCHEM INC - PATENT TRIAL AND APPEAL BOARD HAS DENIED A PETITION FILED BY HOLOGIC FOR INTER PARTES REVIEW Source text for Eikon: Further company coverage:

Apr 24 2018

BRIEF-FDA Approves New Innovations On Hologic's 3Dimensions™ Mammography System

* FDA APPROVES NEW INNOVATIONS ON HOLOGIC'S 3DIMENSIONS™ MAMMOGRAPHY SYSTEM, THE FASTEST, HIGHEST RESOLUTION BREAST TOMOSYNTHESIS SYSTEM EVER(1)

Mar 27 2018

Competitors

Earnings vs. Estimates